Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Studying memory, thinking skills and mood in adults with migraine

Describes thinking skills and mood in adults with migraine and links to their treatment.

Plain-language title generated from the registry record
Registry title: Neuropsychological Profile Characterization in Patients With Migraine: Cognitive Functioning and Psychological Variables

Key facts

Where
Milan, ItalySee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT07233941, who can take part

Where in Italy

  • Fondazione IRCCS Istituto Neurologico Carlo BestaMilan, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Trial code
NCT07233941
Record updated
11 February 2026
Original description
The overall objective is to define the neuropsychological profile of patients with migraine and evaluate its association with: psychological outcome measures (anxiety-depressive symptoms, pain catastrophizing, excessive worry, and coping strategies); the clinical profile of migraine; the prodromal, ictal, or interictal phase of the migraine attack; pharmacological therapy; and detoxification treatment in patients with migraine associated with medication overuse headache.Read full original descriptionShow less

Neuropsychological Profile Characterization in Patients With Migraine: Cognitive Functioning and Psychological Variables

The overall objective is to define the neuropsychological profile of patients with migraine and evaluate its association with: psychological outcome measures (anxiety-depressive symptoms, pain catastrophizing, excessive worry, and coping strategies); the clinical profile of migraine; the prodromal, ictal, or interictal phase of the migraine attack; pharmacological therapy; and detoxification treatment in patients with migraine associated with medication overuse headache.

Inclusion: Written informed consent; Patients aged between 18 and 65 years; Diagnosis of migraine according to the International Classification of Headache Disorders (ICHD-3) criteria; Patients with a history of migraine for at least one year, to ensure the stability of the condition; Stability of ongoing treatment for at least 3 months at baseline; Understanding of the Italian language.

Exclusion: Severe medical or psychiatric conditions (depression, schizophrenia, psychosis) documented by specific previous diagnoses; A history of alcohol or drug abuse; Primary sensory deficits.

ClinicalTrials.gov NCT07233941